Loading…

Schizophrenia, Psychosis, and Cerebral Spinal Fluid Homovanillic Acid Concentrations

Neuroleptic drugs block brain dopamine receptors and are effective in treating psychoses of diverse origins. This finding has become a cornerstone of the dopamine theory of schizophrenia, but clinical studies relating schizophrenia, per se, to brain dopamine metabolism have ranged from controversial...

Full description

Saved in:
Bibliographic Details
Published in:Schizophrenia bulletin 1997, Vol.23 (1), p.147-154
Main Authors: Maas, James W, Bowden, Charles L, Miller, Alexander L, Javors, Martin A, Funderburg, Linda G, Berman, Nancy, Weintraub, Susan T
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Neuroleptic drugs block brain dopamine receptors and are effective in treating psychoses of diverse origins. This finding has become a cornerstone of the dopamine theory of schizophrenia, but clinical studies relating schizophrenia, per se, to brain dopamine metabolism have ranged from controversial to negative. This article presents new evidence that cerebrospinal fluid levels of the dopamine metabolite homovanillic acid are related to the severity of psychosis in schizophrenia. These results support the concept that homovanillic acid levels in cerebrospinal fluid vary as a function of psychosis rather than being related to the diagnosis of schizophrenia per se.
ISSN:0586-7614
1745-1701
DOI:10.1093/schbul/23.1.147